A clinical study to evaluate the effect of meha kulanthaka rasa in type 2 diabetes mellitus

An open-label randomized controlled trail to evaluate the effect of meha kulanthaka rasa in prameha w.s.r type 2 diabetes mellitus - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073614

Enrollment

Registered

2024-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnostic criteria Patients fulfilling the following criteria 1 Signs and symptoms of the Prameha 2 Fasting blood sugar level greater 126mg per dl 3 Post prandial blood sugar level greater 200mg per dl Inclusion criteria Patient fulfilling the diagnostic criteria Patients between the age group 18 to 70 years Fasting blood sugar level up to 250 mg per dl Post prandial blood sugar level up to 300 mg per dL Subjects who are willing to sign the consent form to participate in the research

Exclusion criteria

Exclusion criteria: Type 1 DM FBS greater than 250mg per dl and PPBS greater than 300mg per dl Diabetic complication like cardiomyopathy, Neuropathy, Nephropathy, Retinopathy, Diabetic ketoacidosis. Any life-threatening disorder which interfering with the treatment Pregnant and lactating women Malignant and accelerated hypertension

Design outcomes

Primary

Measure	Time frame
assessment will be done on the basis of subjective and objective parameters 1 subjective parameters avila mootrata ( polyurea ) pipasa adhikya ( polydypsia ) kshuda adhikya ( polyphagia ) dourbalya ( debility ) mukha talu shosha ( dryness of oral cavity ) kara pada daha ( neuropathy) kara pada suptata ( neuropathy ) shithilangata ( fatigue ) 2 objective parameters shareera bharahani prabhootha mutrata fasting blood sugar level post prandial blood sugar level before an at the end of the therapy on 35th dayTimepoint: observation will be made on 0th day, 14th day, 28th day and 35th day	—

Measure

Time frame

assessment will be done on the basis of subjective and objective parameters 1 subjective parameters avila mootrata ( polyurea ) pipasa adhikya ( polydypsia ) kshuda adhikya ( polyphagia ) dourbalya ( debility ) mukha talu shosha ( dryness of oral cavity ) kara pada daha ( neuropathy) kara pada suptata ( neuropathy ) shithilangata ( fatigue ) 2 objective parameters shareera bharahani prabhootha mutrata fasting blood sugar level post prandial blood sugar level before an at the end of the therapy on 35th dayTimepoint: observation will be made on 0th day, 14th day, 28th day and 35th day

—

Secondary

Measure	Time frame
quality of lifeTimepoint: oth day and 35th day	—

Countries

India

Contacts

Public ContactDr Sarala T

sri dharmasthala manjunatheshwara college of ayurveda,hospital and research centre kuthpady udupi

anisaralaya@gmail.com9986102083

Outcome results